Formulation Development

FORMULATION FORUM – Formulation Research Strategy for Discovery-Stage New Drug Candidates

Jim Huang, PhD, and Edward Orton, PhD, say it is critically important CROs or CDMOs that support discovery and preclinical research have the requisite preformulation, formulation, and biopharmaceutics expertise as well as the proprietary methodologies to develop formulations from small quantities of drug candidates for different routes of administration.

EXCLUSIVE ONLINE CONTENT

4/3/2019

CURE Pharmaceutical to Acquire Chemistry Holdings Inc.

CURE Pharmaceutical, an innovative drug delivery and development company, recently announced that it has agreed to acquire Chemistry Holdings Inc., a formulation technology company that is developing innovative delivery systems for a variety of industries, in an all-stock transaction.